REGENERON PHARMACEUTICALS financial statements, including revenue, expenses, profit, and loss

The total revenue of 4REGN for the last quarter is 3.34 B EUR, and it's 0.91% higher compared to the previous quarter. The net income of Q3 24 is 1.20 B EUR.